経カテーテルデバイス市場規模、シェア、成長分析：製品タイプ別、用途別、地域別 - 産業予測 2025～2032年

経カテーテルデバイスの世界市場規模は2023年に118億米ドルと評価され、2024年の133億6,000万米ドルから2032年には360億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは13.2％で成長する見通しです。

世界の経カテーテルデバイス市場は、様々な病状、特に心血管系疾患や心臓の構造的欠陥に対する治療アプローチに大きな利点をもたらす低侵襲手技へのシフトに牽引され、急速に進化しています。主な市場促進要因としては、高齢化、慢性疾患の増加、医療機器の技術進歩などが挙げられます。ヘルスケアプロバイダーも患者も、回復時間の短縮と合併症発生率の低下を優先するため、経カテーテルデバイスは効果的なソリューションとしてますます注目されるようになっています。しかし、規制のハードル、償還の複雑さ、専門的なトレーニングの必要性などの課題が、進歩を妨げる可能性があります。このような障害にもかかわらず、継続的な技術革新とメーカーとヘルスケア従事者の協力的な努力により、市場情勢は将来的に大きく変化するものと思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

経カテーテルデバイス市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 経カテーテル塞栓術および閉塞器具
  • コイル
• 押し込み可能なコイル
  • 取り外し可能なコイル
• コイルなし
  • 流れ転換装置
  • 塞栓粒子
• 液体塞栓
  • その他の塞栓および閉塞器具
  • アクセサリー
• 経カテーテル置換デバイス
  • 経カテーテル大動脈弁置換術
  • 経カテーテル肺弁置換術
  • 経カテーテル僧帽弁置換術
• 経カテーテル修復装置
  • 経カテーテル僧帽弁修復術
  • 経カテーテル三尖弁修復術

経カテーテルデバイス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 心臓血管
• 腫瘍
• 神経
• 泌尿器科
• その他

経カテーテルデバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Edwards Lifesciences Corporation（USA）
• Medtronic（USA）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Bracco SpA（Italy）
• JenaValve Technology Inc.（Germany）
• CryoLife Inc.（USA）
• Lepu Medical Technology Co. Ltd（China）
• Transcatheter Technologies GmbH（Germany）
• MicroPort Scientific Corporation（China）
• Meril Life Sciences Pvt. Ltd（India）
• St. Jude Medical Inc.（USA）
• Direct Flow Medical Inc.（USA）
• Heart Leaflet Technologies Inc.（USA）
• Venus Medtech（China）
• NVT AG（Germany）
• Balton Sp. z o.o.（Poland）
• New Valve Technology（Switzerland）
• HLT Medical（USA）
• Mardil Medical（USA）

結論と提言

Global Transcatheter Devices Market size was valued at USD 11.8 billion in 2023 and is poised to grow from USD 13.36 billion in 2024 to USD 36.02 billion by 2032, growing at a CAGR of 13.2% during the forecast period (2025-2032).

The global transcatheter devices market is rapidly evolving, driven by a shift towards minimally invasive procedures that offer significant advantages in treatment approaches for various medical conditions, particularly cardiovascular diseases and structural heart defects. Key market growth drivers include an aging population, the rising incidence of chronic diseases, and technological advancements in medical devices. As both healthcare providers and patients prioritize shorter recovery times and lower complication rates, transcatheter devices are increasingly viewed as an effective solution. However, challenges such as regulatory hurdles, reimbursement complexities, and the need for specialized training could impede progress. Despite these obstacles, continued innovation and collaborative efforts between manufacturers and healthcare practitioners are poised to transform the future landscape of the transcatheter devices market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Devices Market Segments Analysis

Global Transcatheter Devices Market is segmented by Product Type, Application and region. Based on Product Type, the market is segmented into Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices and Transcatheter Repair Devices. Based on Application, the market is segmented into Cardiovascular, Oncology, Neurology, Urology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcatheter Devices Market

The Global Transcatheter Devices market is significantly influenced by advancements in medical technology, which increasingly prioritize procedures that minimize patient discomfort, shorten hospital stays, and accelerate recovery times. Devices like stents, valves, and embolization tools are essential for facilitating minimally invasive interventions across numerous medical fields. They enable healthcare professionals to access specific body areas through small incisions, eliminating the necessity for conventional open surgeries. As patients increasingly prefer treatments that promise faster recovery and reduced complications, the demand for transcatheter devices continues to grow, fostering innovation and transforming treatment methodologies within the healthcare sector.

Restraints in the Global Transcatheter Devices Market

The global transcatheter devices market faces significant restraints primarily due to the extensive clinical trials and regulatory approvals needed for the development and commercialization of these advanced medical technologies. The complexity of transcatheter procedures and the inherent risks linked with new innovations necessitate thorough evaluations to prioritize patient safety. Additionally, manufacturers must navigate various regulatory frameworks across different regions, which often results in delays in product launches and escalated costs. Consequently, these regulatory hurdles hinder the pace of innovation and the timely entry of products into the market, ultimately constraining the growth of the global transcatheter devices industry.

Market Trends of the Global Transcatheter Devices Market

The global transcatheter devices market is witnessing a notable trend driven by the increasing adoption of Transcatheter Aortic Valve Replacement (TAVR) procedures, emerging as an attractive minimally invasive alternative to conventional open-heart surgery for aortic valve diseases. Particularly beneficial for elderly and high-risk surgical patients, TAVR offers advantages such as expedited recovery, reduced hospitalization, and lower complication rates, aligning with the growing demand for less invasive treatment options. The rising geriatric population, alongside advancements in TAVR techniques, are fueling its uptake worldwide. Furthermore, ongoing R&D efforts are enhancing TAVR technologies, expanding their use and ensuring improved patient outcomes across the global market for transcatheter devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Transcatheter Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Transcatheter Embolization and Occlusion Devices
  • Coils
• Pushable coils
  • Detachable coils
• Non Coils
  • Flow Diverting Devices
  • Embolization Particles
• Liquid Embolics
  • Other Embolization and Occlusion Devices
  • Accessories
• Transcatheter Replacement Devices
  • Transcatheter Aortic Valve Replacement
  • Transcatheter Pulmonary Valve Replacement
  • Transcatheter Mitral Valve Replacement
• Transcatheter Repair Devices
  • Transcatheter Mitral Valve Repair
  • Transcatheter Tricuspid Valve Repair

Global Transcatheter Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiovascular
• Oncology
• Neurology
• Urology
• Others

Global Transcatheter Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application)
  • US
  • Canada
• Europe (Product Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology Inc. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co. Ltd (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transcatheter Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Direct Flow Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heart Leaflet Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NVT AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Sp. z o.o. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New Valve Technology (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLT Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mardil Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations